Concepedia

Stéfano Kim

SK

Statistics

Publications

51

Citations

1.5K

H-Index

25

Active since

2006

Affiliations

Centre Hospitalier Universitaire de Besançon(Current)

Inserm

Methodology and Quality of Life Unit in Oncology

Sorbonne Université

Hôpital Saint-Antoine

Stéfano Kim is an author at Centre Hospitalier Universitaire de Besançon specializing in oncology, medicine, and chemotherapy.

ORCID

Publications per year

2006–2024

51

Publications

51

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study

Stéfano Kim, Éric François, Thierry André et al. · The Lancet Oncology · 2018 · 143 citations

, , +11

Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial

Alice Bernard‐Tessier, Emmanuelle Jeannot, David Guenat et al. · Clinical Cancer Research · 2018 · 95 citations

, , +16

Clinical significance of class III β-tubulin expression and its predictive value for resistance to docetaxel-based chemotherapy in gastric cancer

Naomi Urano, Yoshiyuki Fujiwara, Yuichiro� Doki et al. · International Journal of Oncology · 2006 · 79 citations · Full text

, , +17

A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)

Sheela Rao, Gayathri Anandappa, Jaume Capdevila et al. · ESMO Open · 2022 · 76 citations · Full text

, , +17

DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma

Stéfano Kim, Marine Jary, Luigi Mansi et al. · Annals of Oncology · 2013 · 54 citations · Full text

, , +6

1–5 of 51